Biomarkers in oncology drug development: rescuers or troublemakers?

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.4, Iss.11, 2008-11, pp. : 1391-1402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacodynamic Biomarkers in Model-Based Drug Development in Oncology

Current Clinical Pharmacology, Vol. 6, Iss. 1, 2011-02 ,pp. : 30-40

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges of biomarkers in drug discovery and development

By Goodsaid Federico

Expert Opinion on Drug Discovery, Vol. 7, Iss. 6, 2012-06 ,pp. : 457-461

Informa Healthcare

Access to resources Recommend Favorite

Dynamic Contrast-Enhanced MRI in Oncology Drug Development

Current Clinical Pharmacology, Vol. 2, Iss. 2, 2007-05 ,pp. : 111-122

Bentham Science Publishers

Access to resources Recommend Favorite

Radiopharmaceuticals for Oncology Drug Development: A Pharmaceutical Industry Perspective

Current Pharmaceutical Design, Vol. 15, Iss. 9, 2009-03 ,pp. : 957-965

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Metabolic Disorders, Drug Development, Drug Design and Biomarkers)

Current Pharmaceutical Design, Vol. 22, Iss. 7, 2016-02 ,pp. : 765-767

Bentham Science Publishers

Access to resources Recommend Favorite